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Introduction 51 Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, acts as a 52 modulator of neuronal excitability and synaptic plasticity (Pezet and McMahon, 2006 ). We 53 have previously shown that nociceptor-derived BDNF regulates the excitability of spinal 54 neurons and plays a crucial role in inflammatory pain (Zhao et al., 2006) , supporting other 55 studies that have demonstrated neurotrophin regulation of synaptic transmission and long term 56 plasticity in pain pathways Slack et al., 2004; Melemedjian et al., 2013) . 57
Although multiple studies support the role of BDNF expressed throughout the nervous system 58 in nociceptive processing in the peripheral and central nervous system (Merighi et al., 2008; 59 Ferrini and De Koninck, 2013; Nijs et al., 2015a) , the distinct contribution of primary afferent-60 derived BDNF to chronic pain processing remains undetermined. Here we demonstrate the 61 critical role of BDNF expressed in peripheral sensory neurons in the transition from acute to 62 chronic pain. 63 BDNF expressed in dorsal root ganglia (DRG) is released in an activity-dependent fashion in 64 the spinal dorsal horn to activate trkB receptors on second order neurons or primary afferent 65 endings (Thompson et al., 1999; Lever et al., 2001; Chen et al., 2014) . It has long been known 66 that exogenous BDNF can facilitate spinal reflexes and increase primary afferent evoked post-67 synaptic currents Garraway et al., 2003) . BDNF derived from Nav1.8-68 expressing nociceptive neurons contributes to inflammatory pain induced by intraplantar 69 carrageenan and intramuscular NGF, but does not affect the development of neuropathic pain 70 in a modified Chung model (Zhao et al., 2006) . In contrast, BDNF derived from microglia 71 drives pain behaviour in a model of sciatic nerve cuffing (Coull et al., 2005) , and BDNF visualised on an oscilloscope and discriminated on a spike amplitude and waveform basis using 146 a CED 1401 interface coupled to Spike2 software (Cambridge Electronic Design, UK). Natural 147 stimuli (dynamic brush, vF hairs 0.16g -26g, noxious prod 100 and 150 g cm −2 mechanical 148 stimulation; thermal water jet 35 -45 °C) were applied in ascending order of intensity to 149 receptive fields for 10 s and the total number of evoked spikes recorded. Statistical significance 150 for differences between littermates and Bdnf fl/fl ; Avil-CreERT2 mice was determined using a 2 151 way repeated measures ANOVA with Bonferroni post-tests for all measures. 152
Mouse behaviour

153
All behavioural experiments were performed by an experimenter blind to genotype (Bdnf fl/fl n 154 = 8, Bdnf fl/fl ; Avil-CreERT2 n = 10). Mechanical nociceptive thresholds were measured using 155
Randall-Selitto apparatus (Ugo Basile) that applies pressure to the tail with a 3-mm 2 blunt 156 conical probe using a 500g cutoff. Mechanical sensitivity of the inferior half of the abdomen 157 was assessed using von Frey hair application as described previously (Minett et al., 2014) . 158 9 Rotarod testing was performed over 5 minutes with the initial starting ramp increasing from 159 4rpm to 40rpm over 30s using a mouse-adapted apparatus (IITC). Thermal nociceptive 160 thresholds were determined by measuring hind paw withdrawal latency using the Hargreaves 161 apparatus (IITC) at a ramp of 1.5°C s −1 with a 30s cutoff and latency for nociceptive behaviour 162 on a hot plate (Ugo Basile) at 50°C and 55°C. Thermal place preference plates (Bioseb) were 163 used to determine temperature preference of mice to 30°C (warm), 14°C (cool) and 5°C (cold) 164 temperatures versus a room temperature 20°C plate. All place preference thermal tests were 165 performed with reversed plate temperature settings and the average of the two responses used 166 for statistical analyses. Nociceptive behaviour to cooling acetone was measured following 167 application of one acetone drop to the hind paw and nociceptive behaviours measured for 1 168 minute. Statistical significance for differences between littermates and BDNF knockouts was 169 determined using a t-test. 170
Formalin test
171
The two groups of animals (Bdnf fl/fl n = 6, Bdnf fl/fl ; Avil-CreERT2 n = 6) were singly housed 172 in Perspex boxes and allowed to habituate to the testing environment for 30 minutes. Animals 173 were then injected with formalin (15μl i.pl., 5% dilution of stock formalin (40% w/v) in saline) 174 in the hind paw. Nociceptive behavior was measured as licking and biting of the injected paw 175 only. Nociceptive behaviour was recorded at 5 minute intervals for a duration of 60 minutes 176 and divided in 2 phases, the first phase lasting 0 -10 minutes and the second phase 10-60 min. 177
Statistical significance for differences between littermates and Bdnf fl/fl ; Avil-CreERT2 mice 178 over the time course or for comparison of biphasic behaviour was determined using 2 way 179 repeated measures ANOVA with Bonferroni post-tests and t-test, respectively. 180
Neuropathic pain models
181
Neuropathic pain was assessed with two peripheral nerve injury models. For the partial sciatic 182 nerve ligation model (Seltzer model), the surgical procedure was carried out as previously 183 described (Zhao et al., 2010) . Briefly, animals were anaesthetised using isoflurane. A 0.5 cm 184 incision was made in the skin of the upper left leg and blunt scissors were used to dissect 185 muscle layers apart to access the sciatic nerve. A tight ligation between ½-⅓ of the nerve was 186 made using 6-0 mersilk suture (Ethicon, UK). The skin was closed using 4-0 mersilk sutures 187 (Ethicon, UK). For spinal nerve ligation, a modified version of the Kim and Chung model (Kim 188 and Chung, 1992) of peripheral neuropathy was adapted for use on mice (Minett et al., 2012) . 189
Briefly, under the same anesthesia, a midline incision was made in the skin of the back at the 190 L4-S2 levels and a further incision through the left paraspinal muscle was made to access the 191 transverse processes at the L4-S1 levels. The L4 transverse process was removed using a blunt Mechanical sensitivity of the hind paw was measured using the up-down method to determine 203 the 50% mechanical withdrawal threshold to von Frey application (Chaplan et al., 1994) . The 204 primed group of mice was administered with carrageenan (i.pl. 1% 20μl, Sigma Aldrich) on 205 Day 0, followed by administration of Prostaglandin E2 (PGE2) in the same paw (i.pl. 100ng in 206 25μl, Cayman Chemical) in both primed and unprimed mice on Day 6 (n = 6 in both groups). 207
We We then performed immunohistochemical staining of lumbar DRG sections to determine 234 whether deletion of BDNF from sensory neurons affects survival or population of DRG 235 neurons using small to medium diameter neuron (nociceptor) marker peripherin, and large 236 diameter neuron marker neurofilament heavy chain (NF200). Our data show that most 237 nociceptors were labelled with anti-peripherin, and most large diameter DRG neurons were 238 NF200 positive in both Bdnf fl/fl ; Avil-CreERT2 mice and Bdnf fl/fl mice (Fig. 1B ). There was no 239 apparent difference between Bdnf conditional knockouts and littermate controls in the total 240 number and proportion of neurofilament and peripherin-positive neurons (Fig. 1C and 1D) . 241 This is similar to our previous findings with BDNF deletion from Nav1.8-expressing neurons 242 (Zhao et al., 2006) . CreERT2 mice. Mechanical and thermal stimuli were applied to the peripheral hind paw 247 receptive field of neurons and evoked action potentials were recorded as previously described 248 (Sikandar et al., 2013; Minett et al., 2015) . For mechanical sensory coding, we compared 249 evoked activity of dorsal horn neurons to a range of intensities of punctate vF hairs ( Fig. 2A) , 250 as well as two noxious prods and a low threshold brush stimulation applied to the whole 251 receptive field of the hind paw ( Fig. 2D ). For thermal sensory coding, we compared evoked 252 activity to innocuous and noxious heat ( Standardised behavioural assays were used to asses thermal and mechanical pain thresholds in 261 BDNF knockout mice (Fig. 3) . Deletion of Bdnf from sensory neurons had no impact on motor 262 function, as shown by normal rotarod activities measured in speed (Fig. 3A , t-test, P = 0.21), 263 time spent on the rotarod (Fig. 3B , t-test, P = 0.26) and distance travelled (Fig. 3C , t-test, P = 264 0.18). We also observed no significant difference in mechanical pain thresholds using the 265 Randall-Sellitto test with a noxious probe applied to the paw (Fig. 3D , t-test, P = 0.72) and tail 266 ( Fig. 3E , t-test, P = 0.21) (Randall and Selitto, 1957) . There was also no significant difference 267 14 between these two groups on the 50% mechanical withdrawal thresholds for fine filament von 268
Frey hairs applied to the abdomen (Fig. 3F , t-test, P = 0.99). 269
Thermal place preference for innocuous warm (30C), cool (14C) and noxious cold (5C) 270 revealed no changes in thermal sensory function in the BDNF knockouts (Fig. 3G , t-test, P = 271 0.61, P = 0.91 and P = 0.36, respectively), and thermal pain thresholds in the Hargreaves' test 272 was comparable to littermate controls (Fig. 3H , t-test, P = 0.30) (Hargreaves et al., 1988) . 273
Acetone applied to the hind paw did not evoked significantly different pain behaviours from 274 wildtype mice, also indicating no altered sensitivity to cold stimulation (Fig. 3I , t-test, P = 275 0.47). However, we did observe a hyposensitivity to noxious heat at temperatures of 50C and 276 55C in the hot plate test, which assess supraspinally mediated nociceptive behaviours ( Fig.  277 3J, t-test, P = 002 and P = 0.03, respectively) (Woolfe and Macdonald, 1944) . This mild 278 thermal phenotype is similar to that we have previously reported with BDNF deletion from 279 Nav1.8-expressing DRG neurons (Zhao et al., 2006) . 280 Dunnett's post-tests, P < 0.001 at all time points post-PGE2 in primed group). We used this 314 model to determine the contribution of BDNF to the transition from acute to chronic pain (Fig.  315   6B ). We found that priming with intraplantar injection of carrageenan induced a transient 316 mechanical hypersensitivity in both Bdnf conditional knockouts and littermate controls. 317
Chronic pain models of inflammation, neuropathy and hyperalgesic priming
Intraplantar injection of carrageenan alone is an established model of acute inflammation, and 318 like our findings in the first phase formalin behaviour (Fig. 4) , we observed no difference in 319 nociceptive behaviour between BDNF knockouts and littermate controls. Littermate control 320 mice recovered to baseline thresholds within 72 hours (Fig. 6B, 1 Moreover, behavioural assays measuring acute reflexes to noxious stimuli showed no 368 significant difference between BDNF knockout mice and littermate controls to mechanical, 369 cold and most thermal assays (Fig. 3) . However, the knockout mice were hyposensitive to the 370 hotplate assay -this recruits bulbospinal reflexes, indicating that BDNF expression in sensory 371 ganglia contributes to reflexes mediated from the brainstem. We have previously observed a 372 similar hotplate phenotype following BDNF deletion from Nav1.8-expressing neurons (Zhao 373 et al., 2006) . 374
Several lines of evidence support the role of enhanced DRG and spinal BDNF expression in 375 persistent pain that follows injury-induced sensitisation of nociceptors (Cho et al., 1997; Cho 376 et al., 1998; Lever et al., 2003; Coull et al., 2005; Li et al., 2006; Lin et al., 2011; Melemedjian 377 et al., 2013) . However, the relative importance of BDNF released either from microglia or 378 sensory neurons in chronic pain states is still unclear (Coull et al., 2005; Zhuo et al., 2011), 379 and the contribution of microglial activity to persistent pain is further confounded by well-380 established sex differences in immune-related nociceptive processing (Sorge et al., 2011; Sorge 381 et al., 2015) . In this study, we examine the role of primary afferent-derived BDNF on pain 382 processing using both male and female mice. 383
19
To study the contribution of sensory BDNF to the development and maintenance of chronic 384 pain, we used the formalin model of inflammation, a modified Chung and Seltzer models of 385 neuropathy and a model of hyperalgesic priming. The formalin model entails biphasic pain 386 behaviour -the first phase reflects acute, peripheral hypersensitivity and the second phase 387 relates to chronic maintenance of pain through central sensitisation (Tjolsen et al., 1992; Berge, 388 2011) . We found comparable first phase nocifensive behaviour between BDNF knockouts and 389 littermate controls, but significantly reduced second phase nocifensive behaviour in knockouts 390 ( Fig. 4) . Similarly, we found that nerve-injury induced mechanical hypersensitivity was 391 comparable to littermates in the acute phase following a modified Chung surgery, but BDNF 392 knockout mice showed recovery of pain behaviour in a later chronic phase from 3 weeks after 393 surgery (Fig. 5 ). Our data in the formalin and modified Chung surgery models suggest that 394 BDNF signaling in sensory neurons is important for chronic, but not acute, pain processing. 395
Notably, we did not observe any difference in the development of mechanical hypersensitivity 396 in the Seltzer model between BDNF knockout mice and littermate controls at any time point 397 ( Fig. 5B ). Our observations support previous findings that the development of chronic pain in 398 the modified Chung model is dependent on the expression of BDNF in sensory neurons, unlike 399 partial sciatic nerve ligation . Previous studies have also reported 400 differences in behavioural phenotypes (Kim et al., 1997; Dowdall et al., 2005) and in the 401 contribution of distinct neuronal subsets across different rodent models of neuropathy (Minett 402 et al., 2012) . Moreover, differences in levels of BDNF expression in DRG following distinct 403 rhizotomy and transection models of neuropathy have been reported previously (Obata and 404 Noguchi, 2006b; . 405
We also validated a model of hyperalgesic priming to determine the role of sensory BNDF in 406 the transition from acute to chronic pain. Hyperalgesic priming of the nociceptive system 407 reflects long-lasting, latent hyper-responsiveness of nociceptors to inflammatory mediators 408 20 subsequent to an inflammatory or neuropathic insult (Reichling and Levine, 2009) An important implication of our findings is that BDNF expressed in sensory neurons is not 424 essential for acute pain, but is critical for the transition from acute to chronic pain in models of 425 inflammation, neuropathy and hyperalgesic priming. Studies of long term potentiation suggest 426 that both pre-and post-synaptic release of BDNF regulates consolidation of late-LTP (Dean et 427 al., 2009; Jourdi et al., 2009) , and regulation of aPKCs at spinal synapses is likely to be a 428 mechanism for BDNF to initiate and maintain chronic pain states (Melemedjian et al., 2013) . 429 Different sources of BDNF may also drive nociceptive mechanisms in different preclinical pain 430 models, i.e. the gender-specific contribution of microglial BDNF to chronic pain in a model of 431 sciatic nerve cuffing (Coull et al., 2005) . A mechanistic discrepancy of neurotrophin signaling 432 between rodent models likely underlies our findings that BDNF released from sensory neurons 433 21 is essential for the development of chronic pain in a model of full, but not partial, nerve ligation 434 . 435
In conclusion, our findings demonstrate the pro-nociceptive role of primary-afferent derived 436 BDNF in mediating the transition from acute to chronic pain. These findings support the 437 therapeutic potential of modulating BDNF for chronic pain syndromes (Nijs et al., 2015b) . 438
Because BDNF expression is ubiquitously expressed in the nervous system, the development 439 of targeted gene therapies for subsets of sensory neurons holds promise for providing adequate 440 pain relief and overcoming side effects arising from central modulation (Glorioso and Fink, 441 2009; Fink et al., 2011) . 442 443 22 
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